Title : The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents.

Pub. Date : 2019 Mar 31

PMID : 30639533






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
2 Alternatively, through drug repositioning of approved drugs, we discovered that the FMS-like tyrosine kinase-3 (FLT3) inhibitor midostaurin blocks the drug transport function of ABCB1 and re-sensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic drugs. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
3 Alternatively, through drug repositioning of approved drugs, we discovered that the FMS-like tyrosine kinase-3 (FLT3) inhibitor midostaurin blocks the drug transport function of ABCB1 and re-sensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic drugs. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
4 Our findings were further supported by results demonstrating that midostaurin potentiates drug-induced apoptosis in ABCB1-overexpressing cancer cells and inhibits the ATPase activity of ABCB1. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens
5 Our findings were further supported by results demonstrating that midostaurin potentiates drug-induced apoptosis in ABCB1-overexpressing cancer cells and inhibits the ATPase activity of ABCB1. midostaurin ATP binding cassette subfamily B member 1 Homo sapiens